Azathioprine associated with intrahepatic cholestasis in a patient with twin pregnancy after a second kidney transplant
  • Lamis Khedr
    Nephrology Department, Ain Shams University, Cairo, Egypt
  • Mohamed Ekram
    Internal Medicine Department, New Giza University, Cairo, Egypt

Keywords

Kidney transplant, azathioprine, pregnancy, intrahepatic cholestasis

Abstract

Introduction: Most pregnancies in women after a kidney transplant result in a live birth, but kidney functions should be stable for one year before conception. For immunosuppression modification occurring before pregnancy, azathioprine is used because it is considered safe for major congenital malformations during pregnancy. However, there may be an association between exposure to azathioprine during pregnancy and the onset of an unusual, early and severe form of intrahepatic cholestasis.
Case description: A young patient with a twin pregnancy after a second kidney transplant experienced intrahepatic cholestasis. There was a wide range of differential diagnosis. A battery of tests was requested including autoimmune markers, virology, and imaging. The conclusion that azathioprine was contributing to intrahepatic cholestasis with pregnancy was reached after exclusion of all other differentials.
Conclusions: Complications of pregnancy after a kidney transplant include hypertension, pre-eclampsia, deterioration of graft function up to rejection, but also unusual side effects of immunosuppression medication.

VIEW THE ENTIRE ARTICLE

References

  • Shah S, Venkatesan RL, Gupta A, Sanghavi MK, Welge J, Johansen R, et al. Pregnancy outcomes in women with kidney transplant: metanalysis and systematic review. BMC Nephrol 2019;20:24.
  • Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ 2013;347:f6564.
  • Sousa MV, Guida JPS, Surita FGC, Parpinelli MA, Nascimento MLCD, Mazzali M. Twin pregnancy after kidney transplantation: case report and systematic review. J Bras Nefrol 2021;43:121–126.
  • Ponticelli C, Moroni G. Fetal toxicity of immunosuppressive drugs in pregnancy. J Clin Med 2018;7:552.
  • Céruti H, Kayem G, Guilbaud L, Dussaux C, Gervais A, Beaufrère A, et al. Intrahepatic cholestasis of pregnancy associated with azathioprine: a case series. J Gynecol Obstet Hum Reprod 2021;50:102083.
  • Lauterbach R, Linder R, Vitner D, Solt I. Azathioprine-induced cholestasis of pregnancy – a new insight on azathioprine safety in pregnancy. Eur J Obstet Gynecol Reprod Biol 2020;250:271–272.
  • Chertoff J, Alam S, Black M, Elgendy IY. Azathioprine-induced hepatitis and cholestasis occurring 1 year after treatment. BMJ Case Rep 2014;2014:bcr2014206859.
  • Morton A, Laurie J. The biochemical diagnosis of intrahepatic cholestasis of pregnancy. Obstet Med 2019;12:76–78.
  • Xu T, Deng C, Zhan Y, Hu Q, Huang G, Wang X, et al. Perinatal outcomes associated with ICP in twin pregnancies were worse than singletons: an almost 5-year retrospective cohort study. BMC Pregnancy Childbirth 2022;22:820.
  • Estiu MC, Frailuna MA, Otero C, Dericco M, Williamson C, Marin JJ, et al. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS One 2017;12:e0176504.
  • Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15:2049–2066.
  • Yadav A, Salas MAP, Coscia L, Basu A, Rossi AP, Sawinski D, et al. Acute kidney injury during pregnancy in kidney transplant recipients. Clin Transplant 2022;36:e14668.
  • Gonzalez Suarez ML, Parker AS, Cheungpasitporn W. Pregnancy in kidney transplant recipients. Adv Chronic Kidney Dis 2020;27:486–498.
  • Views: 78
    HTML downloads: 8
    PDF downloads: 72


    Published: 2024-03-11
    Issue: 2024: Vol 11 No 4 (view)


    How to cite:
    1.
    Khedr L, Ekram M. Azathioprine associated with intrahepatic cholestasis in a patient with twin pregnancy after a second kidney transplant. EJCRIM 2024;11 doi:10.12890/2024_004385.